Ed Silverman

Report: Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815 million in 2023.

Pharmalittle: We're reading about unsupported drug price hikes, an annual HIV prevention shot, and more

A bipartisan group of senators are filing a bill that would force health insurers or PBMs to divest their pharmacy businesses

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on

The pharmaceutical industry is not lobbying senators to stop the confirmation of long-time critic Robert F. Kennedy Jr.

The Ohio Supreme Court ruled CVS, Walmart, and Walgreens could not be held liable for contributing to the opioid crisis under a state nuisance law.

The BIOSECURE Act, which would restrict drugmakers from using key Chinese contract manufacturers, was left out of a defense budget bill 

The diverse alliance that makes up the MAHA movement is showing some cracks over Trump's picks to lead health-related agencies

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the